REMOVED: Long Donor Leukocyte Telomeres Increase the Risk of Severe COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplant
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been removed because it was not presented at the 2025 BMT Tandem Meeting.
Authors
- Simon Verhulst (ORCID: https://orcid.org/0000-0002-1143-6868)
- James M. Anderson (ORCID: https://orcid.org/0000-0003-2765-7996)
- Abraham Aviv (ORCID: https://orcid.org/0000-0002-7441-0227)
- Wael Saber (ORCID: https://orcid.org/0000-0002-6544-5815)
- Kyra Jennifer Waligora Mendez
- Stephen R. Spellman (ORCID: https://orcid.org/0000-0002-7271-8252)
- Shahinaz M. Gadalla (ORCID: https://orcid.org/0000-0002-3255-8143)
- Tsung-Po Lai
Institutions
- Rutgers, The State University of New Jersey (US)
- National Marrow Donor Program (US)
- University of Groningen (NL)
- University of Washington (US)
- Medical College of Wisconsin (US)
- National Cancer Institute (US)
- Cancer Genetics (United States) (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- Transplantation and Cellular Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.jtct.2025.01.574
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00